Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CRAD-B.STthis companyC-Rad AB (publ)	SEK 23.60	103.06×	3.12×	2.45×	16.63×	-54.3%	69.2%	10.2%	2.4%	3.0%	8.3%	4.6%	0.03×	-2.92×	49.18×	3.09×	0.0%	4	5.23	4	A-
BICO.STBICO Group AB (publ)	SEK 23.75	-1.36×	0.85×	0.99×	-48.97×	-130.1%	38.9%	-16.8%	-72.7%	-62.3%	-7.9%	3.7%	0.86×	-6.38×	-0.78×	1.27×	0.0%	6	-2.84	3	B-
ITECH.STI-Tech AB	SEK 62.60	18.78×	3.58×	3.71×	9.05×	172.1%	28.2%	26.5%	19.7%	19.0%	20.3%	10.3%	0×	-2.82×	47.44×	9.11×	3.3%	5	14.46	4	A-
ONCO.STOncopeptides AB (publ)	SEK 1.82	-4.37×	-18.53×	15.35×	-5.24×	-767.7%	83.0%	-317.6%	-350.9%	423.8%	-230.4%	-20.4%	-2.37×	-0.26×	-15.63×	2.63×	0.0%	3	0.46	1	D+
OSSD.STOssDsign AB (publ)	SEK 3.91	-24.65×	4.04×	6.95×	-23.99×	-4832.4%	96.3%	-26.8%	-28.3%	-16.4%	-13.3%	-5.7%	0×	4.29×	-1,051.26×	6.97×	0.0%	0	0.72	2	C+
SEDANA.STSedana Medical AB (publ)	SEK 9.64	-17.13×	1.13×	5.1×	-92.41×	-488.3%	71.3%	-16.1%	-29.6%	-6.6%	-3.5%	-7.4%	0.01×	8.53×	-22.12×	3.4×	0.0%	2	10.28	2	C+
Peer median	—	-4.37×	1.13×	5.1×	-23.99×	-488.3%	71.3%	-16.8%	-29.6%	-6.6%	-7.9%	-5.7%	0×	-0.26×	-15.63×	3.4×	0.0%	3	0.72	2	—